Unplugging JAK/STAT in Chronic Myelomonocytic Leukemia. [electronic resource]
- Clinical cancer research : an official journal of the American Association for Cancer Research 08 2016
- 3707-9 p. digital
Publication Type: Letter; Comment
1557-3265
10.1158/1078-0432.CCR-16-0372 doi
Antinematodal Agents--therapeutic use Granulocyte-Macrophage Colony-Stimulating Factor--metabolism Humans Janus Kinases--metabolism Leukemia, Myelomonocytic, Chronic--drug therapy Nitriles Pyrazoles--therapeutic use Pyrimidines STAT Transcription Factors--metabolism Signal Transduction--drug effects Treatment Outcome